Skip to main content
. 2022 Jun 8;11(1):2085432. doi: 10.1080/2162402X.2022.2085432

Figure 7.

Figure 7.

LAMs depletion in the TAME synergizes the antitumorigenic effects of anti-PD1 therapy.

(a) Balb/c mice inoculated with EMT6 cells were treated with anti-PD1 blocker and clophosome as scheduled. (b) The levels of CD163 are quantified by ImageJ after staining with the specific antibodies in paraffin-embedded tissues obtained from murine tumors. (c) Representative immunohistochemical images of CD163. (d-f) Growth curves (mean ± SEM), the representative images of tumors and tumor weight distributions at day 20 were shown.